Sponsored Content
Listen to our Podcast on Tuberculosis Screening Options Pros and Cons
Listen to our Podcast on Making Sense of TB Testing Guidelines
Download our Supplement on Importance of Screening for Tuberculosis Infection in the Ob/Gyn Community
Though easily screened for, prevented and treated, tuberculosis is a leading cause of non-obstetrical death worldwide in reproductive age women, and significantly increases risk of maternal and fetal morbidity and mortality.
In this Contemporary OB/GYN® podcast, Lee P. Shulman, MD, FACMG, FACOG, discusses screening selectivity to reach high-risk populations, advantages of using an in-vitro blood test based on interferon-gamma release assay over a skin test with purified protein derivative, and appropriate treatment steps for patients testing positive.
Presented by: Lee P. Shulman, MD, FACMG, FACOG
Lee P. Shulman MD is the Anna Ross Lapham Professor in Obstetrics and Gynecology in the Division of Clinical Genetics at the Feinberg School of Medicine at Northwestern University in Chicago, Illinois. He also serves as the Medical Director of Insight Medical Genetics and Reproductive Genetics Innovations. Dr. Shulman is an Adjunct Professor in the Department of Medicinal Chemistry and Pharmacognosy at the University of Illinois at Chicago College of Pharmacy. A Fellow of the American College of Obstetricians and Gynecologists and a Founding Fellow of the American College of Medical Genetics, Dr. Shulman is a member of numerous regional, national and international organizations that pertain to the health and care of women and families. His work has been recognized regionally and nationally; most recently, he was again included in the list of “Top Doctors” in Chicago (2007-20) and America (2005-20). Dr. Shulman served as Chair of the Board of Trustees of the Association of Reproductive Health Professionals from 2006-2008, is a Past President of the Central Association of Obstetricians and Gynecologists and the current Chair of the Fetoscopy Working Group. A frequent contributor to the peer-reviewed and informational literature with over 200 peer-reviewed articles and 60 book chapters, Dr. Shulman’s major research interests are in reproductive and cancer genetics, contraception and reproductive medicine, menopause, women’s healthcare advocacy and botanical interventions in women’s health.
Emerging multiplex UTI testing drives Medicare costs amid increased utilization
November 27th 2024A recent study found a sharp rise in Medicare claims for multiplex urinary tract infection testing from 2016 to 2023, underscoring a significant financial impact and the need for further research into its clinical benefits.
Read More
Reduced subsequent births reported after severe maternal morbidity
November 26th 2024Women experiencing severe maternal morbidity during their first pregnancy face significantly lower odds of subsequent births, emphasizing the need for personalized reproductive counseling and ongoing monitoring.
Read More
Maternal sFLT1 and EDN1 linked to late-onset preeclampsia
November 25th 2024A new study highlights the association of maternal soluble Fms-like tyrosine kinase 1 and endothelin 1 with preeclampsia severity, offering insights into the pathogenesis of early- and late-onset forms of the condition.
Read More
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More